Hong Liag Wu

Director of Finance/CFO presso Jumpcan Pharmaceutical Co. Ltd.

46 anni

Health Technology

Profilo

Hong Liag Wu is currently working as the Chief Financial Officer & Secretary at Jumpcan Pharmaceutical Co. Ltd.
Previously, Wu worked as the Chief Financial Officer & Board Secretary at Hubei Jumpcan Pharmaceutical Co., Ltd.

Posizioni attive di Hong Liag Wu

Società	Posizione	Inizio
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Director of Finance/CFO	-

Tutte le posizioni attive di Hong Liag Wu

Precedenti posizioni note di Hong Liag Wu

Società	Posizione	Fine
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di Hong Liag Wu

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hong Liag Wu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Health Technology

Aziende private	1
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Health Technology